1/33
Flashcards covering pain pathophysiology, subjective and objective assessment, analgesic classes, patient-controlled analgesia, opioid safety, and clinical nursing interventions.
Pain
An unpleasant sensory and emotional experience associated with actual or potential tissue damage; clinically defined as whatever the experiencing person says it is, existing whenever the experiencing person says it does.
Transduction
The first phase of the ascending pain pathway in which a painful insult or noxious stimulus initiates electrical impulses at the peripheral tissue level.
Transmission
The second phase of the ascending pain pathway involving the propagation of neural pain signals from the injured peripheral site up the spinal cord to the brain.
Perception (Pain Pathway)
The third phase of the ascending pain pathway where the conscious physiological and emotional experience of pain occurs within the brain.
Modulation
The descending phase of the pain pathway down the spinal cord where neural signals are altered, either stimulatory or inhibitory, along the nerve pathway.
Pain-Producing Mediators
Endogenous substances released during tissue injury that promote or transmit painful impulses, specifically including Substance P, prostaglandins, bradykinin, and histamine.
Nociceptive Pain
Pain arising from direct mechanical, thermal, or chemical damage to bodily tissues, categorized into visceral and somatic pain.
Visceral Pain
Poorly localized nociceptive pain originating from injury or damage to internal organs, typically described by patients as pressure, aching, squeezing, or cramping.
Somatic Pain
Well-localized nociceptive pain caused by stimulation of pain receptors in bodily tissues rather than internal organs, characteristically described as a constant aching or gnawing sensation.
Deep vs. Superficial Somatic Pain
The two classifications of somatic pain based on tissue depth: superficial pain originates in cutaneous tissues (such as a canker sore on the inner cheek), while deep pain originates in deeper structures like muscles, bones, or tendons (such as a tendon tear).
Neuropathic Pain
Pain resulting from damage to or dysfunction of the nervous system causing nerves to misfire without a specific injury, characterized as electric, jolting, burning, freezing, numbness, tingling, shooting, or stabbing.

Referred Pain
Pain perceived at a cutaneous or anatomical site distant from its actual internal visceral origin, such as myocardial ischemia causing pain radiating to the left arm or jaw.
COLDERR Mnemonic
A systematic subjective assessment framework for pain evaluation comprising Character, Onset, Location, Duration, Exacerbation, Relief, and Radiation.
Acute Pain
Pain with a short history of onset lasting days or weeks, typically accompanied by anxiety, pain behaviors (such as moaning, rubbing, or splinting), and sympathetic hyperactivity signs including tachycardia, hypertension, elevated respiratory rate, dilated pupils, and perspiration.
Chronic Pain
Pain persisting over a long duration with an often poorly-defined onset; physiological vitals adapt to normal ranges (normal blood pressure, heart rate, respiratory rate, pupil size, and dry skin), while vegetative signs (lassitude, anorexia, weight loss, insomnia, loss of libido) and depression or irritability predominate.
Tolerance
A physiological state occurring after repeated, long-term exposure to an opioid analgesic (such as chronic opioid use in malignancy) where increasingly higher drug doses are required to produce the same analgesic effect.
Physical Dependence
A physiological state resulting from repeated opioid exposure characterized by the occurrence of withdrawal symptoms (agitation, insomnia, diarrhea, sweating, and tachycardia) if the drug is abruptly withdrawn; withdrawal symptoms are not a sign of addiction.
Psychological Dependence
A condition marked by overwhelming involvement with obtaining and using a drug for a high, commonly manifested clinically as drug-seeking behavior.
Pain AIR Cycle
The standardized continuous clinical nursing process consisting of Assess, Intervention, and Reassessment of effectiveness.
Analgesic Reassessment Timeframes
The required clinical intervals to re-evaluate patient comfort following analgesic administration: 1hour after oral (PO) medications, and 20−30minutes after intramuscular (IM) or intravenous (IV) medications.
Ceiling Effect
A pharmacological characteristic of non-opioid analgesics where increasing the dose beyond a certain limit produces no additional analgesic efficacy, only increased risk of adverse effects.
Non-Opioid Analgesics
Analgesic medications designed for mild to moderate pain that act on the peripheral nervous system and demonstrate a ceiling effect; includes acetaminophen (best for fever and body aches), NSAIDs such as ibuprofen (best for injuries and inflammatory conditions), and skeletal muscle relaxants.
Opioid Analgesics
Centrally acting narcotic medications designed for moderate to severe pain that bind to central nervous system opioid receptors and lack a pharmacological ceiling effect; examples include morphine, hydromorphone, codeine, and oxycodone.
Adjuvant Analgesics
Medications administered in conjunction with primary analgesics to enhance pain control, such as anticonvulsants, antidepressants, corticosteroids, and local anesthetics.
Opioid-Induced Respiratory Depression
A major adverse effect of narcotic administration defined in adults as a respiratory rate less than 12breaths/min, occurring most frequently during the first 24hours postoperatively.
Naloxone (Narcan)
An opioid antagonist indicated for opioid-induced respiratory arrest, hypoxemia, or bradypnea; administered in medical-surgical settings as an emergent full 0.4mg dose repeated every 2−3minutes as needed, or as a 4mg nasal spray.
Patient-Controlled Analgesia (PCA)
An intravenous or epidural drug delivery system that allows clients to self-administer prescribed doses of pain medication on demand without risk of overdose, providing sustained serum concentrations.
PCA Lockout Interval
A programmed safety duration (such as 10minutes or 15minutes) during which the PCA pump will not deliver medication even if the patient activates the demand button.
Basal Rate (PCA)
A continuous background infusion of analgesic delivered by a PCA pump every hour independently of patient-initiated bolus doses.
PCA Hourly Documentation
The essential parameters logged every hour by the nurse to evaluate PCA therapy: number of button attempts, total doses administered, and medication volume remaining.

Epidural Analgesia
Analgesia delivered via a catheter placed between the spinal vertebrae and the dura mater, enabling medication to diffuse across the dura mater into cerebrospinal fluid to bind with opioid receptors in the dorsal horn of the spinal cord.
Geriatric Opioid Dosing Principle
The clinical pharmacology standard dictating that initial opioid doses in older adults should begin at 50%−75% of the normal young adult dose, recognizing that while pain is not a normal part of aging, older adults possess increased vulnerability to drug side effects.
Narcotic Waste Witnessing
The mandatory protocol where a second clinician visually witnesses the physical disposal of partial-dose narcotic medication vials, suspensions, or tablets at the Pyxis before cosigning, protecting against diversion and liability.
Scheduled vs. PRN Medication Regimen
The comparative administration approach where scheduled round-the-clock dosing maintains steady therapeutic pain control, whereas strictly as-needed (PRN) administration produces wide fluctuations between toxicity peaks and uncontrolled pain troughs.
